Peer Review Committee for Immunology and Blood Cell Development (IBCD)

Areas Reviewed

• Immune responses to cancer including active and passive immune therapies for cancer, adoptive transfer of autologous or allogeneic hematopoietic cells, and targeted delivery of toxic payloads
• Immune tolerance and hematopoiesis
• Molecular, structural, biochemical, and biophysical aspects of the immune system including cell types, cytokines, antigen processing, antibody molecules, and deficiencies

Peer Review Committee Members

Chair, Jose Guevara-Patino, MD, PhD, H. Lee Moffit Cancer Center and Research Institute
Co-Chair, Irina Pinchuk, PhD, Penn State University
Stakeholder, Joe Dziobek
Stakeholder, Alia Manetta
Stakeholder, Alexandra Solowinska
Mark Boldin, MD, PhD, Beckman Research City of Hope
Challice Bonifant, MD, PhD, Johns Hopkins University
Fan Dong, MD, PhD, University of Toledo
Sergei Grivennikov, PhD, Cedars-Sinai
Andras Heczey, MD, Baylor University
Rosa Lapalombella, PhD , Ohio State University
Li Ling, PhD, Beckman Research City of Hope
Max Mamonkin, PhD, Baylor University
Bethany Mundy-Bosse, PhD, Ohio State University
Raj Muthusamy, PhD, DVM, Ohio State University
Russ Pachynski, MD, Washington University, St. Louis
Robin Parihar, MD, PhD, Baylor University
Chris Porter, MD, Emory University
Zhijian Qian, PhD, University of Florida
Andrew Rezvani, MD, Stanford University
Mark Rubinstein, PhD, Ohio State University
Deepa Sampath, PhD, MD Anderson Cancer Center
Jianhua Yu, PhD, Beckman Research City of Hope
Jerry Zhu, MD, PhD, Brigham and Women’s Hospital